Latest Apella Capital, LLC Stock Portfolio
$7.88Billion | No. of Holdings #759
Apella Capital, LLC Performance
2026 Q3+0.37%
YTD+2.05%
2025+12.31%
About Apella Capital, LLC and 13F Hedge Fund Stock Holdings
On 2026-10-08, the fund reported it's updated stock portfolio. In the 13F Holdings report, Apella Capital, LLC reported an equity portfolio of $7.9 Billions as of 30 Sep, 2026. <br><br> The top stock holdings of Apella Capital, LLC are DFAC, VB, DFAC. The fund has invested 9.8% of it's portfolio in DIMENSIONAL ETF TRUST and 3.7% of portfolio in VANGUARD INDEX FDS. <br><br> The fund managers got completely rid off DIMENSIONAL ETF TRUST (DFAC), EXXON MOBIL CORP (XOM) and SEI EXCHANGE TRADED FUNDS stocks. They significantly reduced their stock positions in SEI EXCHANGE TRADED FUNDS, INVESCO EXCH TRD SLF IDX FD (BSAE) and CROWDSTRIKE HLDGS INC (CRWD). Apella Capital, LLC opened new stock positions in DFA INVT DIMENSIONS GROUP IN, J P MORGAN EXCHANGE TRADED F (BBAX) and ISHARES TR (AAXJ). The fund showed a lot of confidence in some stocks as they added substantially to ISHARES TR (AAXJ), UNITED AIRLS HLDGS INC (UAL) and SCHWAB STRATEGIC TR (FNDA).
Apella Capital, LLC Equity Portfolio Value
Last Reported on: 08 Oct, 2026
$7.88Billion
as of Oct 08, 2026Apella Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Apella Capital, LLC made a return of 0.37% in the last quarter. In trailing 12 months, it's portfolio return was 3.82%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| dfa invt dimensions group in | 184,859,000 |
| exxonmobil holdings corp | 26,550,300 |
| j p morgan exchange traded f | 23,509,400 |
| dfa invt dimensions group in | 20,952,000 |
| j p morgan exchange traded f | 18,534,100 |
| dfa invt dimensions group in | 9,230,080 |
| sandisk corp | 1,953,090 |
| j p morgan exchange traded f | 1,526,740 |
New stocks bought by Apella Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ishares tr | 2,186 |
| united airls hldgs inc | 1,898 |
| schwab strategic tr | 1,256 |
| ishares tr | 714 |
| western digital corp | 685 |
| schwab strategic tr | 536 |
| ishares tr | 447 |
| vanguard world fd | 433 |
Additions to existing portfolio by Apella Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| crowdstrike hldgs inc | -68.79 |
| martin marietta matls inc | -42.26 |
| ishares tr | -34.49 |
| ishares tr | -32.67 |
| j p morgan exchange traded f | -32.36 |
| global x fds | -32.32 |
| j p morgan exchange traded f | -31.49 |
| vanguard index fds | -30.62 |
Apella Capital, LLC reduced stake in above stock
Sold off
None of the stocks were completely sold off by Apella Capital, LLC
Sector Distribution
Apella Capital, LLC has about 90.5% of it's holdings in Others sector.
- Others
- Technology
| Sector | % |
|---|---|
| Others | 90.5 |
| Technology | 3.7 |
Market Cap. Distribution
Apella Capital, LLC has about 9.2% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MEGA-CAP
- LARGE-CAP
| Category | % |
|---|---|
| UNALLOCATED | 90.5 |
| MEGA-CAP | 6.3 |
| LARGE-CAP | 2.9 |
Stocks belong to which Index?
About 8.6% of the stocks held by Apella Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- S&P 500
| Index | % |
|---|---|
| Others | 91 |
| S&P 500 | 8.6 |
| Top 5 Losers ($) | $ | |
|---|---|---|
| DFAC | dimensional etf trust | -8.9 M |
| DFAC | dimensional etf trust | -5.9 M |
| BIV | vanguard bd index fds | -5.4 M |
| DFAC | dimensional etf trust | -4.7 M |
| DFAC | dimensional etf trust | -4.7 M |
Apella Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Apella Capital, LLC
Apella Capital, LLC has 759 stocks in it's portfolio. About 32.3% of the portfolio is in top 10 stocks. DFAC proved to be the most loss making stock for the portfolio. MSFT was the most profitable stock for Apella Capital, LLC last quarter.
$7.80BTotal Value
499Positions
08 Oct, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
| 1.51% | 354,187 | $119.24M 1.51% | 5.05%increased 5.05 percentadded | ||
 AAXJ Ishares TrIshares TrAAXJ | 0.65% | 488,398 | $51.01M 0.65% | 17.57%increased 17.57 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.45% | 394,591 | $35.82M 0.45% | 21.41%increased 21.41 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.26% | 200,528 | $20.16M 0.26% | 3.6%increased 3.6 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.16% | 236,278 | $12.72M 0.16% | 15.43%increased 15.43 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.11% | 113,348 | $8.85M 0.11% | 1.43%decreased 1.43 percentreduced | |
AAXJ Ishares TrIshares TrAAXJ | 0.11% | 75,945 | $8.36M 0.11% | 2186.81%increased 2186.81 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.1% | 101,719 | $7.68M 0.1% | 0.34%decreased 0.34 percentreduced | |
AAXJ Ishares TrIshares TrAAXJ | 0.07% | 108,175 | $5.54M 0.07% | 23.41%increased 23.41 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.05% | 127,164 | $3.73M 0.05% | 8.21%decreased 8.21 percentreduced | |
AAXJ Ishares TrIshares TrAAXJ | 0.05% | 59,776 | $3.71M 0.05% | 0.85%decreased 0.85 percentreduced | |
AAXJ Ishares TrIshares TrAAXJ | 0.04% | 29,104 | $3.30M 0.04% | 314.59%increased 314.59 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.03% | 31,752 | $2.66M 0.03% | 189.34%increased 189.34 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.03% | 14,616 | $2.32M 0.03% | 101.02%increased 101.02 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.02% | 8,094 | $1.30M 0.02% | 447.26%increased 447.26 percentadded | |
AAXJ Ishares TrIshares TrAAXJ | 0.01% | 11,532 | $1.11M 0.01% | 0%unchanged 0 percentunchanged | |
AAXJ Ishares TrIshares TrAAXJ | 0.01% | 8,871 | $1.06M 0.01% | Newnew position | |
AAXJ Ishares TrIshares TrAAXJ | 0.01% | 39,708 | $687.4K 0.01% | 4.15%decreased 4.15 percentreduced | |
 Abbvie Inc Abbvie IncABBV Apella Capital, LLC's holding in Abbvie Inc over time | 0.08% | 23,477 | $6.37M 0.08% | 14.16%increased 14.16 percentadded | |
 Abbott Laboratories Apella Capital, LLC's holding in Abbott Laboratories over time | 0.02% | 14,023 | $1.38M 0.02% | 21.62%increased 21.62 percentadded | |
